BIOPTION AB has a total of 25 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and pharmaceuticals are VIRXSYS CORP, BIOMARIN TECH BV and NKMAX CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Finland | 3 | |
#7 | Japan | 1 | |
#8 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Garoff Henrik | 24 |
#2 | Liljestroem Peter | 15 |
#3 | Suomalainen Maarit | 7 |
#4 | Sjoeberg Mathilda | 6 |
#5 | Liljestrom Peter | 3 |
#6 | Sjoberg Mathilda | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005026316A2 | Alphavirus vaccines | |
US6770283B1 | DNA expression systems based on alphaviruses | |
AU2582695A | Alphavirus expression vector | |
AU2155795A | Alphavirus cDNA vectors | |
CA2614365A1 | Dna expression systems based on alphaviruses |